Thomsen Bioscience ready to launch unique biochip  

North Jutland based Thomsen Bioscience is ready to launch a biochip for biological warfare detection. The US and UK armed services have shown great interest in the product

Thomsen Bioscience, a Danish company based in north Jutland, is ready to launch a unique biochip for biological warfare detection. The chip, a Biological Warfare Agent deteCtion system (BWAC), has been developed over the last four years in collaboration with the Danish, Swedish and Canadian armed services. Berlingske Tidende, which reports the news, says that the US and UK military have shown great interest in the new product.

The BWAC system is no bigger than a credit card yet contains a micro-laboratory which can react to even the weakest concentrations of biological warfare agents. In addition, the biochip can reveal outbreaks of diseases such as SARS, EBOLA and tuberculosis. To cover a country the size of Denmark a total of around 5,000 biochips are needed. The BWAC system is estimated to have substantial commercial potential.

Thomsen Bioscience was founded on 1st September 2001, just one week before 9/11, with the aim of developing a biological warfare detection device based on intelligent biochips. Within days of the attack on the World Trade Centre, a development contract was signed with the Danish and Swedish Ministries of Defence to develop a biochip. The company is based in Norresundby in north Jutland.

Link > Thomsen Bioscience 

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×